Novartis (NVS) Earnings Date, Estimates & Call Transcripts $126.54 -0.36 (-0.28%) Closing price 03:59 PM EasternExtended Trading$126.53 0.00 (0.00%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Novartis Earnings Summary Novartis issued Q2 2025 earnings on July 17, 2025, reporting an EPS of $2.42, which topped the consensus estimate of $2.38 by $0.04. Quarterly revenue rose 12.3% year-over-year to $14.05 billion, above analysts' expectations of $13.94 billion. With a trailing EPS of $6.87 and a P/E Ratio of 18.42, Novartis' earnings are expected to grow 4.26% next year, from $8.45 to $8.81 per share. Upcoming Q3 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Jul. 17) $2.38 Actual EPS (Jul. 17) $2.42 Beat By $0.04 Actual Revenue (Jul. 17) $14.05BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckNVS Upcoming EarningsNovartis' next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Novartis Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novartis and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataNVS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Novartis Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$1.96$1.96$1.96Q2 20251$2.34$2.34$2.34Q3 20251$2.25$2.25$2.25Q4 20251$2.09$2.09$2.09 FY 2025 4 $8.64 $8.64 $8.64 Q1 20261$2.26$2.26$2.26Q2 20261$2.69$2.69$2.69Q3 20261$2.21$2.21$2.21Q4 20261$2.16$2.16$2.16 FY 2026 4 $9.32 $9.32 $9.32 Q1 20271$2.26$2.26$2.26Q2 20271$3.20$3.20$3.20 Novartis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------7/17/2025Q2 2025$2.38$2.42+$0.04$2.06$13.94B$14.05B4/29/2025Q1 2025$2.12$2.28+$0.16$1.83$12.92B$13.23B1/31/2025Q4 2024$1.80$1.98+$0.18$1.41$12.86B-10/29/2024Q3 2024$1.94$2.06+$0.12$2.55$12.62B$12.82B7/18/2024Q2 2024$1.87$1.97+$0.10$2.35$12.24B$12.87B4/23/2024Q1 2024$1.73$1.80+$0.07$2.29$11.50B$11.83B1/30/2024Q4 2023$1.64$1.53 -$0.11-$1.08$11.69B$11.42B10/23/2023Q3 2023$1.70$1.74+$0.04$2.63$12.05B$11.78B Novartis Earnings - Frequently Asked Questions When is Novartis' earnings date? Novartis has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on NVS's earnings history. Did Novartis beat their earnings estimates last quarter? In the previous quarter, Novartis (NYSE:NVS) reported $2.42 earnings per share (EPS) to beat the analysts' consensus estimate of $2.38 by $0.04. Learn more on analysts' earnings estimate vs. NVS's actual earnings. How can I listen to Novartis' earnings conference call? The conference call for Novartis' latest earnings report can be listened to online. Listen to Conference Call How can I read Novartis' conference call transcript? The conference call transcript for Novartis' latest earnings report can be read online. Read Transcript How much revenue does Novartis generate each year? Novartis (NYSE:NVS) has a recorded annual revenue of $50.32 billion. How much profit does Novartis generate each year? Novartis (NYSE:NVS) has a recorded net income of $11.94 billion. NVS has generated $6.87 earnings per share over the last four quarters. What is Novartis' price-to-earnings ratio? Novartis (NYSE:NVS) has a trailing price-to-earnings ratio of 18.42 and a forward price-to-earnings ratio of 14.97. The price/earnings-to-growth ratio is 1.78. What is Novartis' EPS forecast for next year? Novartis' earnings are expected to grow from $8.45 per share to $8.81 per share in the next year, which is a 4.26% increase. More Earnings Resources from MarketBeat Related Companies AstraZeneca Earnings Date Novo Nordisk A/S Earnings Date Sanofi Earnings Date GSK Earnings Date Takeda Pharmaceutical Earnings Date argenex Earnings Date BeOne Medicines Earnings Date Insmed Earnings Date BioNTech Earnings Date Teva Pharmaceutical Industries Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NYSE:NVS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access